3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
Titel:
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
Auteur:
Iveson, Timothy J Kerr, Rachel S Saunders, Mark P Cassidy, Jim Hollander, Niels Henrik Tabernero, Josep Haydon, Andrew Glimelius, Bengt Harkin, Andrea Allan, Karen McQueen, John Scudder, Claire Boyd, Kathleen Anne Briggs, Andrew Waterston, Ashita Medley, Louise Wilson, Charles Ellis, Richard Essapen, Sharadah Dhadda, Amandeep S Harrison, Mark Falk, Stephen Raouf, Sherif Rees, Charlotte Olesen, Rene K Propper, David Bridgewater, John Azzabi, Ashraf Farrugia, David Webb, Andrew Cunningham, David Hickish, Tamas Weaver, Andrew Gollins, Simon Wasan, Harpreet S Paul, James
Verschenen in:
Lancet oncology
Paginering:
Jaargang 19 (2018) nr. 4 pagina's 562-578
Jaar:
2018
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license